Penile cancer begins in the penis and includes various types such as: basal cell penile cancer, melanoma, sarcoma, and epidermoid/squamous cell carcinoma. Squamous cell carcinoma is the most common form of penile cancer. Penile cancer is a relatively uncommon cancer as it only accounts for 10% of all male cancers. Risk factors for developing penile cancer include exposure and infection from the human papillomavirus (HPV), age, smoking, phimosis, an HIV/Aids infection, and poor personal hygiene. Treatment for penile cancer includes surgery, laser therapy, radiation therapy, chemotherapy, and supportive/palliative care. Metastatic penile cancer occurs when the cancer has spread to various locations in the body. When this occurs, the cancer generally becomes incurable--treatments tend to focus on alleviating pain and symptoms rather than attacking the cancer itself.
Metastatic Penile Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Metastatic Penile Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 580 products for the study of Metastatic Penile Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Metastatic Penile Cancer is also known as Metastatic Carcinoma Of Penis, Metastatic Carcinoma Of The Penis, Metastatic Penile Carcinoma, Metastatic Penis Cancer, Stage Iv Penile Cancer.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.